100% Secure Payments
Tender Details
- Country: Germany
- Summary: Drugs Containing the Active Substance Dasatinib (Atc: L01ea02)
- KWT Ref No: 77720526
- Deadline: 27 Dec 2024
- Competition: ICB
- Financier: Self Financed
- Purchaser Ownership: Public
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 044192-2023
- Purchaser's Detail :
- Description :
- The subject of this publication is the conclusion of non-exclusive discount agreements according to Section 130a Paragraph 8 SGB V for finished medicinal products with the active ingredient dasatinib (ATC: L01EA02) as part of a so-called "open-house model". Under the specification of uniform contract conditions and a uniformIn the access procedure, all suitable and interested pharmaceutical companies or associations of pharmaceutical companies are offered the opportunity to conclude or join a discount agreement in accordance with Section 130 a (8) SGB V for the active ingredients listed under Section B. Interested pharmacistsCommercial companies can request the participation documents and the respective contract from the contact address given under I.1). A prerequisite for the conclusion of a contract is that the interested pharmaceutical company completely fills out the requested participation documentst and signed.
Doc Title: Pharmaceutical products
Contract Type: Supplies - Documents :
Purchaser : AOK SAXONY-ANHALT
Address : Lueneburger Str. 4
Town : Magdeburg
NUTS-Code : DEE03 - Magdeburg, Kreisfreie Stadt
Postal Code : 39106
Contact Point : Nadine Sommermeier
Phone : 49 391287845117
Fax : 49 3912878845117
Email :openhouse@san.aok.de
URL :https://san.aok.de/
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGIN
